To view this email as a web page, click here.
 
BREAST CANCER
 
Combination pack approved for breast cancer treatment
FDA approves ribociclib plus letrozole to treat a subset of advanced breast cancer patients.
Read more
 
Breast cancer biosimilar shows equivalency to brand
Two studies on a biosimilar to Herceptin to treat HER2-positive metastatic breast cancer and HER2-positive gastric cancer show surprising results.
Read more
 
Top 5 specialty drug management issues
The 13th edition EMD Serono Specialty Digest outlines top specialty drug management issues health plans face.
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.